Background: A clinical model is needed to compare inhaled corticosteroids (ICSs) with
respect to efficacy. Objective: The purpose of this investigation was to compare the relative …

Inhaled corticosteroids (ICS) remain a vital part of the management of persistent asthma, but
concerns have been raised about their potential adverse effects in children. This review …

The National Asthma Education and Prevention Program (NAEPP) published an update on
selected topics from the 1997 Guidelines for the Diagnosis and Management of Asthma and …

Background Although guidelines recommend daily therapy for patients with mild persistent
asthma, prescription patterns suggest that most such patients use these so-called controller …

The severe adverse effects of chronic oral corticosteroids, including suppression of the
hypothalamo-pituitary-adrenal (HPA) axis, growth failure, and delays in skeletal maturation …

Inhaled corticosteroids are being given to more patients, at increasing doses and for longer
periods of time. This has led to renewed concern about side-effects, particularly when higher …

Inhaled corticosteroids have revolutionized the treatment of asthma and have now become
the mainstay of therapy for patients with chronic disease (1). In a supplement to this journal …

BACKGROUND: Inhaled corticosteroids (ICSs) are the most effective therapy for the
management of persistent asthma. The aim of ICS therapy is to achieve a high anti …

BACKGROUND: Daily controller medication use is recommended for children with persistent
asthma to achieve asthma control. OBJECTIVE: To examine patterns of inhaled …

BACKGROUND: The Inhaled Steroid Treatment as Regular Therapy in Early Asthma
(START) study is a worldwide, randomized, prospective study to investigate early …